Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
SPRY
— ARS Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 15, 2026
REVENUE
$22.7M
-19.2%
NET MARGIN
-267.3%
-120.1 PTS
EPS
-$0.61
-45.2%
FREE CASH FLOW
-$44.9M
-3.4%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →